1887

n South African Medical Journal - A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab : in practice - case report

USD

 

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder with no prevalence or incidence studies in sub-Saharan Africa. Acquired TTP has several causes, all of which lead to decreased activity of von Willebrand factor cleaving protease (ADAMTS13) due to autoantibodies that are directed towards ADAMTS13. We report a case of a 46-year-old man who presented with most of the classic clinical manifestations of TTP.

Loading

Article metrics loading...

/content/m_samj/106/7/EJC191228
2016-07-01
2016-12-09
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error